Quest Diagnostics Incorporated ( DGX) - Stock Earnings
DGX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 22, 2026 BeforeMarket | 3.00 / — | — | 3.1 billion / — | — |
DGX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 245.0 million USD | 2.8 billion USD |
| 2026Q1 | 252.0 million USD | 2.9 billion USD |
| 2026Q2 | 320.0 million USD | 3.0 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DGX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 854.0 million USD | 9.3 billion USD |
| 2024 | 871.0 million USD | 9.9 billion USD |
| 2025 | 992.0 million USD | 11.0 billion USD |
| 2026 Est. | — | — |
DGX
List: Contenders
Price: $241.89
Dividend Yield: 1.42%
Forward Dividend Yield: 1.42%
Payout Ratio: 40.49%
Dividend Per Share: 3.44 USD
Earnings Per Share: 9.41 USD
P/E Ratio: 25.00
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.3 million
Ebitda: 346.0 millionMarket Capitalization: 25.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR3: -0.64%
DGR5: 8.46%
DGR10: 9.13%
DGR20: 13.74%